Cosmo Pharmaceuticals’ Shareholders approve all Agenda Items at Annual General Meeting FOR ELEVIEW® TO ALL COUNTRIES EXCEPT CANADA
Cosmo Pharmaceuticals N.V.
/ Key word(s): AGMEGM
Dublin, Ireland – 27 May 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) today announced that its shareholders approved all agenda items at today's virtual annual general meeting of shareholders. 8,315,019 ordinary shares in the share capital of Cosmo were represented at this virtual annual general meeting of shareholders constituting 47.40% of the total outstanding ordinary shares in the share capital of Cosmo (as of the record date).
About Cosmo Pharmaceuticals Contact Disclaimer
End of Media Release |
Language: | English |
Company: | Cosmo Pharmaceuticals N.V. |
Riverside 2, Sir John Rogerson’s | |
Dublin 2 Dublin | |
Ireland | |
Phone: | + 353 1 817 0370 |
E-mail: | info@cosmopharma.com |
Internet: | https://www.cosmopharma.com/ |
ISIN: | NL0011832936 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1363359 |
End of News | EQS News Service |
Editor Details
-
Company:
- EQS Newsfeed
- Website: